|
인쇄하기
취소
|
MSD to launch anti-fungal drug, Cancidas in June.
Published: 2003-06-04 06:57:00
Updated: 2003-06-04 06:57:00
MSD Korea will launch Cancidas 70mg and 50mg strength (IV injection) for the treatment of fungal infections probably during June.
Mode of Cancidas (caspofungin acetate) action is to block beta (1.3)-D-glucan, which is a component of fungus wall, primarily indicating for the invasive Aspergillosis.
MSD Korea said that Cancidas is indicative for the invasive aspergillosis when other remedi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.